A single-center experience: Enteropathic arthritis in inflammatory bowel diseases

Basit Öğe Kaydı
dc.authoridBulut Gokten, Dilara/0000-0002-9226-7532
dc.contributor.authorCabuk, Baris
dc.contributor.authorGokten, Dilara Bulut
dc.contributor.authorSolakoglu, Tevfik
dc.contributor.authorMete, Rafet
dc.contributor.authorKucukmetin, Nurten Turkel
dc.contributor.authorMercan, Ridvan
dc.date.accessioned2024-10-29T17:58:24Z
dc.date.available2024-10-29T17:58:24Z
dc.date.issued2024
dc.departmentTekirdağ Namık Kemal Üniversitesi
dc.description.abstractAim of the work: To ascertain the frequency of enteropathic arthritis among patients diagnosed with inflammatory bowel disease (IBD) and to investigate the relation between spondyloarthritis (SpA) and patients treated for IBD. Patients and methods: This study examined 124 adult patients with IBD. The evaluation encompassed both axial and peripheral SpA. Information pertaining to the patients ' age, gender, age at the time of IBD and SpA diagnosis, symptoms of inflammatory low back pain (iLBP), dactylitis, peripheral arthritis, history of uveitis, pelvic X-ray, sacroiliac joint magnetic resonance imaging (MRI), ankylosing spondylitis disease actviity score (ASDAS) and Bath ankylosing spondylitis disease actvity index (BASDAI) were compiled. Results: The IBD patients were 82 having ulcerative colitis (UC) and 42 Crohns disease (CD). 58 (46.8 %) were female and 66 (53.2 %) males. 36 (29 %) were diagnosed with SpA, 18 males and 18 females. The age of the patients was 49 +/- 11.2 years (18 -74 years). The duration of IBD was 5.96 +/- 5.54 years (1 -29 years). Sacroiliitis was assessed in 60 (48.3 %) patients using MRI. None of the patients had psoriasis or uveitis. Dactylitis was present in 1.6 % and enthesitis in 8 % of patients with IBD. In UC group, 18 (21.9 %) were diagnosed with SpA and in CD group, 18 (42.8 %) had SpA. No significant relationship was found between the diagnosis of UC/CD and the general SpA group. Conclusion: A considerable number of individuals with IBD also experience SpA. Any delay in diagnosing enteropathic arthritis could lead to functional limitations. Therefore, timely diagnosis is crucial to facilitate optimal treatment.
dc.identifier.doi10.1016/j.ejr.2024.07.001
dc.identifier.endpage174
dc.identifier.issn1110-1164
dc.identifier.issn2090-2433
dc.identifier.issue4en_US
dc.identifier.scopus2-s2.0-85197119169
dc.identifier.scopusqualityQ4
dc.identifier.startpage171
dc.identifier.urihttps://doi.org/10.1016/j.ejr.2024.07.001
dc.identifier.urihttps://hdl.handle.net/20.500.11776/14290
dc.identifier.volume46
dc.identifier.wosWOS:001265851500001
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherElsevier
dc.relation.ispartofEgyptian Rheumatologist
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectEnteropathic arthritis
dc.subjectInflammatory bowel disease
dc.subjectSpondyloarthritis
dc.titleA single-center experience: Enteropathic arthritis in inflammatory bowel diseases
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu